Japanese Generics Ready Major Launches This Summer

Japanese makers of generic drugs plan major launches of their products this summer, but no branded drug is expected to attract as much attention as Pfizer's Amlodipine (amlodipine besylate) for treating hypertension. A total of 38 companies have clearance from Japan's Health Ministry to sell a generic version of Amlodipine, the country's best-selling drug whose patent protection expired in March. Sawai's version is expected on the market in July. (Click here for more - a subscription may be required